MedTrace Logo

Safety and Performance of the SinuSys Dilation System for Dilation of the Maxillary Sinus Ostium

NCT01623050 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-11-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess safety and performance of the SinuSys Dilation System for dilation of the maxillary sinus ostium.

Conditions

  • Sinusitis

Interventions

DEVICE

SinuSys Dilation System

Sinuplasty

Sponsors & Collaborators

  • SinuSys Corporation

    lead INDUSTRY

Principal Investigators

  • Peter Catalano, MD · St Elizabeth Medical Center

  • Amin Javer, MD · St. Paul's Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2013-06-30
Completion
2014-09-30

Countries

  • United States
  • Canada
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01623050 on ClinicalTrials.gov